Danish Novo Nordisk will test the weight loss drug Cagrisema on children and adolescents. (Archive photo). Photo: Mads Claus Rasmussen/Ritzau Scanpix
Novo’s new obesity hope to be tested on kids as young as 8
Danish pharmaceutical company Novo Nordisk plans to study the effects of Cagrisema in treating childhood obesity. According to Bloomberg News reported by MarketWire, Novo confirmed they will begin trials on January 8. The study will involve 460 children as young as eight, via 97 test centers in...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?